Jason S Schneider
Overview
Explore the profile of Jason S Schneider including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cooney E, Reisner S, Poteat T, Radix A, Mayer K, Beyrer C, et al.
AJPM Focus
. 2025 Mar;
4(2):100313.
PMID: 40051448
Introduction: Pre-exposure prophylaxis (PrEP) use among transgender women in the U.S. has not reached levels optimal to change the trajectory of the HIV epidemic owing to multilevel barriers. Long-acting injectable...
2.
Cooney E, Stevenson M, Aguayo-Romero R, Valera G, Poteat T, Mayer K, et al.
AIDS Behav
. 2024 Dec;
29(3):804-816.
PMID: 39636555
HIV incidence among transgender women remains high and disproportionately impacts young, Black, and Latina transgender women. Data on preferred PrEP modalities among this population are limited. Participants in The LITE...
3.
Wirtz A, Poteat T, Borquez A, Linton S, Stevenson M, Case J, et al.
JMIR Res Protoc
. 2024 Aug;
13:e59846.
PMID: 39190916
Background: In the United States, transgender women are disproportionately impacted by HIV and prioritized in the national strategy to end the epidemic. Individual, interpersonal, and structural vulnerabilities underlie HIV acquisition...
4.
Loeb T, Murray S, Cooney E, Poteat T, Althoff K, Cannon C, et al.
BMC Public Health
. 2024 Jan;
24(1):243.
PMID: 38245684
Background: Transgender women (TW) experience significant inequities in healthcare access and health disparities compared to cisgender populations. Access to non-transition related healthcare is understudied among TW. We aimed to assess...
5.
Sherman A, Higgins M, Balthazar M, Hill M, Klepper M, Schneider J, et al.
J Nurs Scholarsh
. 2024 Jan;
56(1):42-59.
PMID: 38228564
Introduction: Existing literature suggests that transgender women (TW) may be at high risk for adverse mental health due to stress attributed to combined experiences of stigma and complex social and...
6.
Cooney E, Saleem H, Stevenson M, Aguayo-Romero R, Althoff K, Poteat T, et al.
J Int AIDS Soc
. 2023 Dec;
26(12):e26199.
PMID: 38123897
Introduction: Transgender women in the United States experience high HIV incidence and suboptimal Pre-exposure prophylaxis (PrEP) engagement. We sought to estimate PrEP initiation and discontinuation rates and characterize PrEP discontinuation...
7.
Wirtz A, Humes E, Althoff K, Poteat T, Radix A, Mayer K, et al.
Lancet HIV
. 2023 Mar;
10(5):e308-e319.
PMID: 36868260
Background: Epidemiological monitoring of HIV among transgender women is minimal despite prioritisation of this group in the US National HIV/AIDS Strategy (2022-2025). We aimed to estimate HIV incidence in a...
8.
Poteat T, Humes E, Althoff K, Cooney E, Radix A, Cannon C, et al.
J Correct Health Care
. 2022 Aug;
29(1):60-70.
PMID: 36037064
This study characterized arrest, incarceration, and risk factors for incident incarceration among transgender women (TW) in the northeastern and southern United States. During semiannual study visits over 24 months in...
9.
Cooney E, Reisner S, Saleem H, Althoff K, Beckham S, Radix A, et al.
Ann Epidemiol
. 2022 Apr;
70:23-31.
PMID: 35398255
Purpose: Adherence to pre-exposure prophylaxis (PrEP) during periods of PrEP-indication (i.e., prevention-effective adherence) is critical for preventing HIV. We sought to describe factors associated with prevention-effective adherence trajectories among transgender...
10.
Malone J, Reisner S, Cooney E, Poteat T, Cannon C, Schneider J, et al.
J Acquir Immune Defic Syndr
. 2021 Aug;
88(1):10-18.
PMID: 34397742
Introduction: Preexposure prophylaxis (PrEP) is effective in preventing HIV among adherent users. However, PrEP uptake among transgender women is low, and current prescribing guidelines from the Centers for Disease Control...